cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
G1 Therapeutics Inc
7 own
11 watching
Current Price
$4.08
$-0.23
(-5.34%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
146.2M
52-Week High
52-Week High
5.00000
52-Week Low
52-Week Low
1.08000
Average Volume
Average Volume
0.57M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.333
iconMarket Capitalization146.2M
icon52-Week High5.00000
icon52-Week Low1.08000
iconAverage Volume0.57M
iconDividend Yield--
iconP/E Ratio21.333
What does the G1 Therapeutics Inc do?
N/A
Read More
How much money does G1 Therapeutics Inc make?
News & Events about G1 Therapeutics Inc.
Globe Newswire
11 months ago
RESEARCH TRIANGLE PARK, N.C., April 26, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate update for the first quarter 2023 on Wednesday May 3, 2023, at 8:30 a.m. ET. Please...
Globe Newswire
1 year ago
RESEARCH TRIANGLE PARK, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1s Chief Executive Officer Jack Bailey and other members of the Executive Team will participate in a fireside chat during the 22nd Annual ...
Zolmax
1 year ago
Shares of G1 Therapeutics, Inc. (NASDAQ:GTHX Get Rating) have received a consensus recommendation of Moderate Buy from the six brokerages that are covering the stock, Marketbeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1...
Zolmax
1 year ago
Shares of G1 Therapeutics, Inc. (NASDAQ:GTHX Get Rating) have earned an average rating of Moderate Buy from the six ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy ...
Globe Newswire
1 year ago
RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a corporate and financial update for the fourth quarter and full year 2022 on Wednesday, March 1, 2023, at 8:...
Frequently Asked Questions
Frequently Asked Questions
What is G1 Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy G1 Therapeutics Inc shares?
plus_minus_icon
How can I buy G1 Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of G1 Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in G1 Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of G1 Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of G1 Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of G1 Therapeutics Inc?
plus_minus_icon
What percentage is G1 Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is G1 Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.08
$-0.23
(-5.34%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00